Theravance Biopharma Inc
NASDAQ:TBPH
Theravance Biopharma Inc
Pre-Tax Income
Theravance Biopharma Inc
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theravance Biopharma Inc
NASDAQ:TBPH
|
Pre-Tax Income
-$49.3m
|
CAGR 3-Years
45%
|
CAGR 5-Years
26%
|
CAGR 10-Years
11%
|
See Also
What is Theravance Biopharma Inc's Pre-Tax Income?
Pre-Tax Income
-49.3m
USD
Based on the financial report for Dec 31, 2023, Theravance Biopharma Inc's Pre-Tax Income amounts to -49.3m USD.
What is Theravance Biopharma Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
11%
Over the last year, the Pre-Tax Income growth was 47%. The average annual Pre-Tax Income growth rates for Theravance Biopharma Inc have been 45% over the past three years , 26% over the past five years , and 11% over the past ten years .